Pase Paediatric Drops contains clonazepam, a benzodiazepine medicine that calms overactive nerve signals in the brain. It is used as part of seizure treatment in children, and the doctor decides how it is used.
There are 69 brands of Clonazepam listed in Bangladesh. 23 of them have a lower unit price than Pase. The lowest listed price is Clonazepam 2 mg Tablet at ৳ 6 per unit.
What is Pase 2.5 mg/ml Paediatric Drops?
Pase Paediatric Drops is a benzodiazepine medicine supplied by Opsonin Pharma Limited as a 2.5 mg/ml oral drop in a 10 ml drop pack. Clonazepam works by strengthening the effect of GABA, a natural calming chemical in the brain, which helps reduce excessive nerve activity. In children it is used as an adjunct in the treatment of seizure disorders. Because it can cause drowsiness and other effects, it is given only under medical supervision, and the doctor sets the dose and course for each child.
Uses of Pase
Pase Paediatric Drops is used in children as an adjunct anti-epileptic medicine, meaning it is given alongside other treatment for seizure disorders. Clonazepam belongs to the benzodiazepine group, which reduces excessive nerve activity in the brain. It is not a treatment that parents should start or adjust themselves; the child's doctor decides whether it is suitable and how it fits into the overall seizure plan.
How to use Pase
Give Pase Paediatric Drops only in the way the child's doctor has instructed. The doctor decides the dose and how long it is continued, based on the child's condition and response. Measure the drops carefully as advised and do not change the amount on your own. If a dose is missed or the child seems unwell, contact the doctor or pharmacist rather than adjusting the medicine yourself.
Side effects of Pase
Drowsiness is a common effect of clonazepam, and some children may also have problems with balance or coordination, or changes in behaviour. Other effects reported with clonazepam include confusion, mood changes, unusual eye movements, tremor, dizziness and sleep problems. Some effects may lessen over time. Tell the child's doctor about any side effect that worries you, and seek urgent medical help if the child has serious breathing difficulty or unusual sleepiness.
Safety and precautions
Clonazepam is not suitable for children with a known allergy to benzodiazepines or with significant liver disease, and it should not be used in acute narrow angle glaucoma. It may interact with other medicines, so tell the doctor about everything the child takes. Use in pregnancy and breastfeeding is decided by the doctor, who weighs the possible risks; clonazepam should only be used in pregnancy if the doctor considers it necessary. Ask the doctor or pharmacist before use if the child has other health conditions.
Frequently asked questions
What is the price of Pase Paediatric Drops?
The listed price is ৳ 80.3.
What does the generic name clonazepam mean?
Clonazepam is the generic name of the active ingredient. It belongs to the benzodiazepine group of medicines, which act on the brain's calming GABA signalling. Pase is the brand name under which Opsonin Pharma Limited supplies this ingredient as paediatric drops.
What is Pase Paediatric Drops used for and what kind of medicine is it?
It is a benzodiazepine used in children as an adjunct, meaning alongside other treatment, in the management of seizure disorders. It is an anti-epileptic medicine that helps calm excessive nerve activity. The child's doctor decides whether it is appropriate and how it is used.
Is Pase Paediatric Drops safe in pregnancy or breastfeeding?
Pregnancy and breastfeeding use must be decided by a doctor. Clonazepam has been associated with possible risks to the unborn baby, so it is used in pregnancy only when the doctor judges it necessary. If breastfeeding, ask the doctor or pharmacist before use, as they will weigh the benefits and risks.
It is indicated for the treatment of panic disorder, with or without agoraphobia. Panic disorder is characterized by the occurrence of unexpected panic attacks and associated concern about having additional attacks, worry about the implications or consequences of the attacks.
It is also indicated ... Read moreIt is indicated for the treatment of panic disorder, with or without agoraphobia. Panic disorder is characterized by the occurrence of unexpected panic attacks and associated concern about having additional attacks, worry about the implications or consequences of the attacks.
It is also indicated alone or as an adjunct in the treatment of the Lennox-Gastaut Syndrome (petit mal variant), akinetic and myoclonic seizures. It may be indicated in patients with absence seizures (petit mal) who have failed to respond to succinimides.
The effectiveness of Clonazepam in long-term use, that is, for more than 9 weeks, has not been systematically studied in controlled clinical trials. The physician who elects to use Clonazepam for extended periods should periodically reevaluate the long-term usefulness of the drug for the individual patient.
Pharmacology
Clonazepam exhibits pharmacological properties which are common to benzodiazepines and include anticonvulsive, sedative, muscle relaxing and anxiolytic effects. The central actions of benzodiazepines are mediated through an enhancement of the GABAergic neurotransmission at inhibitory synapses. In the presence of benzodiazepines the affinity of the GABA receptor for the neurotransmitter is enhanced through positive allosteric modulation resulting in an increased action of released GABA on the postsynaptic transmembrane chloride ion flux.
There are also animal data showing an effect of clonazepam on serotonin. Animal data and electroencephalographic investigations in man have shown that clonazepam rapidly suppresses many types of paroxysmal activity including the spike and wave discharge in absences seizures (petit mal), slow spike wave, generalized spike wave, spikes with temporal or other locations as well as irregular spikes and waves. Generalized EEG abnormalities are more regularly suppressed than focal abnormalities. According to these findings clonazepam has beneficial effects in generalized and focal epilepsies.
Dosage & Administration
Oral:
Adults: The initial dose for adults with seizure disorders should not exceed 1.5 mg/day divided into three doses. Dosage may be increased in increments of 0.5 to 1 mg every 3 days until seizures are adequately controlled or until side effects preclude any further increase. Maintenance dosage must be individualized for each patient depending upon response. Maximum recommended daily dose is 20 mg.
The initial dose for adults with panic disorder is 0.25 mg given in two divided dose. An increase to the target dose for most patients of 1 mg/day may be made after 3 days.
Pediatric Patients: In order to minimize drowsiness, the initial dose for infants and children (up to 10 years of age or 30 kg of body weight) should be between 0.01 and 0.03 mg/kg/day but not to exceed 0.05 mg/kg/day given in two or three divided doses.
Injection:
Infants and children: half of a vial (0.5 mg) by slow IV injection or by IV infusion.
Adults: 1 vial (1 mg) by slow IV injection or by IV infusion. This dose can be repeated as required (1-4 mg are usually sufficient to reverse the status). In adults, the rate of injection must not exceed 0.25 - 0.5 mg per minute (0.5-1.0 ml of the prepared solution) and a total dose of 10 mg should not be exceeded.
Interaction
Clonazepam does not appear to alter the pharmacokinetics of phenytoin, carbamazepine or phenobarbital. The effect of Clonazepam on the metabolism of other drugs has not been investigated.
Contraindications
It should not be used in patients with a history of hypersensitivity to benzodiazepines, nor in patients with clinical or biochemical evidence of significant liver disease. It may be used in patients with open angle glaucoma who are receiving appropriate therapy but is contraindicated in acute narrow angle glaucoma.
Side Effects
The most frequently occurring side effects of Clonazepam are referable to CNS depression. Experience in treatment of seizures has shown that drowsiness has occurred in approximately 50% of patients and ataxia in approximately 30%. In some cases, these may diminish with time; behavior problems have been noted in approximately 25% of patients. Abnormal eye movements, aphonia, coma, tremor, vertigo, confusion, depression, amnesia, hallucinations, hysteria, increased libido, insomnia, psychosis & palpitations may also occur.
Pregnancy & Lactation
Pregnancy: From preclinical studies it cannot be excluded that clonazepam possesses the possibility of producing congenital malformations. From epidemiological evaluations there is evidence that anticonvulsant drugs act as teratogens. However, it is difficult to determine from published epidemiological reports which drug or combination of drugs is responsible for defects in the newborn. The possibility also exists that other factors e.g. genetic factors or the epileptic condition itself may be more important than drug therapy in leading to birth defects. Under these circumstances, the drug should only be administered to pregnant women if the potential benefits outweigh the risk to the foetus. During pregnancy, Clonazepam may be administered only if there is a compelling indication. Administration of high doses in the last trimester of pregnancy or during labour can cause irregularities in the heartbeat of the unborn child and hypothermia, hypotonia, mild respiratory depression and poor feeding in the neonate. It should be borne in mind that both pregnancy itself and abrupt discontinuation of the medication can cause exacerbation of epilepsy. Withdrawal symptoms in newborn infants have occasionally been reported with benzodiazepines.
Nursing Mothers: Although the active ingredient of Clonazepam has been found to pass into the maternal milk in small amounts only, mothers undergoing treatment with this drug should not breastfeed. If there is a compelling indication for Clonazepam, breastfeeding should be discontinued.
Precautions & Warnings
When used in patients in whom several different types of seizure disorders coexist, Clonazepam may increase the incidence or precipitate the onset of generalized tonic-clonic seizures. This may require the addition of appropriate anticonvulsants or an increase in their dosages. The concomitant use of valproic acid and Clonazepam may produce absence status.
Overdose Effects
Symptoms: Benzodiazepines commonly cause drowsiness, ataxia, dysarthria and nystagmus. Overdose of Clonazepam is seldom life-threatening if the drug is taken alone, but may lead to areflexia, apnoea, hypotension, cardiorespiratory depression and coma. Coma, if it occurs, usually lasts a few hours but it may be more protracted and cyclical, particularly in elderly patients. Increased frequency of seizures may occur in patients at supratherapeutic plasma concentrations. Benzodiazepine respiratory depressant effects are more serious in patients with respiratory disease. Benzodiazepines increase the effects of other central nervous system depressants, including alcohol.
Treatment: Monitor the patient’s vital signs and institute supportive measures as indicated by the patient’s clinical state. In particular, patients may require symptomatic treatment for cardiorespiratory effects or central nervous system effects. Further absorption should be prevented using an appropriate method e.g. treatment within 1-2 hours with activated charcoal. If activated charcoal is used airway protection is imperative for drowsy patients. In case of mixed ingestion gastric lavage may be considered, however not as a routine measure. If CNS depression is severe consider the use of flumazenil, a benzodiazepine antagonist. This should only be administered under closely monitored conditions. It has a short half-life (about an hour), therefore patients administered flumazenil will require monitoring after its effects have worn off. Flumazenil is to be used with extreme caution in the presence of drugs that reduce seizure threshold (e.g. tricyclic antidepressants). Refer to the prescribing information for flumazenil, for further information on the correct use of this drug.
Storage Conditions
Keep in a dry place away from light and heat. Keep out of the reach of children.
Alternative brands of Clonazepam
Other brands with the same generic name, cheapest first.